Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Oscar Health reported strong second-quarter results, swinging to a profit of $362 million compared to a loss of $228.4 million a year ago. | CEO Mark Bertolini said during Thursday’s earnings call the company brought in $1.1 billion in earnings and $1 billion in net income for the first half of 2026.
Oscar Health posted $362M profit, raised FY guidance to $500-700M on 46% growth and improved MLR. Scalable tech, disciplined pricing, and products reversed margin collapse—key learning for IT leaders in healthcare and enterprise cost optimization.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook

Insurer Oscar Health swung to a $361 million second quarter profit while eclipsing $1 billion in net income for the first six…

Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call

Oscar Health shares surged after the company reaffirmed its 2026 outlook and provided a business update.

OSCR stock dived despite a big earnings beat. Oscar Health management is bullish on the outlook, but big ACA Marketplace coverage…

Oscar Health shares reach fresh 52-week highs Wednesday, extending an 80% YTD rally after Monday's guidance reaffirmation.